Incidence and Prognostic of Cardiac Surgery-Associated Acute Kidney Injury: A Spanish Multicenter Study (SCARS-AKI)
SCARS-AKI
External Validation Study of a Laboratory-based Perioperative Prediction Model for Acute Kidney Injury After Cardiac Surgery.
1 other identifier
observational
2,500
1 country
1
Brief Summary
To predict the renal damage caused by cardiac surgery in patients to try to mitigate it as soon as possible
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedFirst Submitted
Initial submission to the registry
January 12, 2026
CompletedFirst Posted
Study publicly available on registry
January 27, 2026
CompletedJanuary 27, 2026
January 1, 2026
1 year
January 12, 2026
January 21, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
- Confirm the usefulness and externally validate the Demijirian scale.
Validate scale
up to 14th postoperative day
- Compare this scale with other models of AKI prediction after cardiac surgery: Thakar, Mehta, ISR, Callejas, Leicester, CRATE.
Score validation
up to 14th postoperative day
Secondary Outcomes (4)
- Identify new risk factors for Acute Kidney Injury (AKI)
from surgery to 4months postoperative
- Validating a model for predicting discharge dialysis after cardiac surgery
from surgery to 4monts postoperative
risk factors for new Chronic Kidney Disease (CKD)
from surgery to 4months postoperative
Drugs related with CSA AKI
from surgery to 4months postoperative
Interventions
PATIENTS UNDERGOING CARDIAC SURGERY
Eligibility Criteria
All patients over 18 years old undergoing all types of major cardiac surgery
You may qualify if:
- All patients over 18 years of age undergoing cardiac surgery.
You may not qualify if:
- Exitus in the first 48h postoperative period
- Patient undergoing renal replacement therapy or preoperative dialysis
- Minor" cardiac surgery ( sternal dehiscence, MCP removal or implantation, pericardial window)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
HUCA
Oviedo, Principality of Asturias, 33011, Spain
Related Publications (3)
Demirjian S, Bashour CA, Shaw A, Schold JD, Simon J, Anthony D, Soltesz E, Gadegbeku CA. Predictive Accuracy of a Perioperative Laboratory Test-Based Prediction Model for Moderate to Severe Acute Kidney Injury After Cardiac Surgery. JAMA. 2022 Mar 8;327(10):956-964. doi: 10.1001/jama.2022.1751.
PMID: 35258532RESULTMehta RH, Grab JD, O'Brien SM, Bridges CR, Gammie JS, Haan CK, Ferguson TB, Peterson ED; Society of Thoracic Surgeons National Cardiac Surgery Database Investigators. Bedside tool for predicting the risk of postoperative dialysis in patients undergoing cardiac surgery. Circulation. 2006 Nov 21;114(21):2208-16; quiz 2208. doi: 10.1161/CIRCULATIONAHA.106.635573. Epub 2006 Nov 6.
PMID: 17088458RESULTLange HW, Aeppli DM, Brown DC. Survival of patients with acute renal failure requiring dialysis after open heart surgery: early prognostic indicators. Am Heart J. 1987 May;113(5):1138-43. doi: 10.1016/0002-8703(87)90925-2.
PMID: 3578008RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luis Baeza Alvarez, MD
Universidad de Oviedo
- STUDY DIRECTOR
Marc Vives Santacana, PhD
Clinica Universidad de Navarra
- STUDY DIRECTOR
Pablo Avanzas Fernández, PhD
Universidad de Oviedo
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 12, 2026
First Posted
January 27, 2026
Study Start
September 1, 2023
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
January 27, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
Not necessary